Press releases
- GSK completes acquisition of Sierra Oncology
- GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community
- Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
Tweets from GSK US
-
GSKUS @GSKUS
As June comes to a close, we want to recognize the incredible work and allyship from our colleagues. From workshops to webinars, speeches to safe spaces, parades to pictures, we marked #Pride2022 and #Juneteenth this month. See what diversity and pride mean to them 👇
about 5 days ago -
GSKUS @GSKUS
#News for #investors and #media: Today we have announced results from a clinical trial of a bivalent adjuvanted COVID-19 vaccine candidate we co-developed with @sanofi.
about 11 days ago -
GSKUS @GSKUS
Meet our #chemists today at the Empowering Women in Organic Chemistry conference @EWOC8. See you at the networking sessions! #EWOC8 #EWOC2022 #GSKChemistry #DiversityEquityInclusion #WomenInChemistry
about 12 days ago
